7 October 2024 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice on five medicines.

Selinexor (Nexpovio) was accepted for treating adults with multiple myeloma, a type of cancer that affects the plasma cells in the bone marrow.

Read SMC press release